Global equities lost ground as the COVID-19 crisis intensified, with the emergence of two new variants in Brazil adding to the UK and South African mutations. The UK removed [...]

Global stocks notched the best weekly gains since last November. The ‘blue wave’ trade picked up speed as the run-off election result in Georgia means the Democrats will [...]

Global stocks ended the year on a strong note, boosted by further US fiscal stimulus, a Brexit deal, and a growing number of countries approving COVID-19 vaccines. However, [...]

Global equities generally advanced as COVID-19 vaccine rollouts, central bank pledges and hopes of an end to political wrangling on both sides of the Atlantic helped to lift [...]

As the UK started to vaccinate its most vulnerable citizens, the US approved the BioNTech/Pfizer vaccine. However, global stocks generally eased amid rising fears of a [...]

Global stocks extended their rise into record territory, boosted by hopes that a vaccine will unlock pent-up savings and spur recovery. Meanwhile, bonds, particularly in [...]

Global stocks gained on further good news on the vaccine front. Oxford University and AstraZeneca announced that their vaccine had between 62% and 90% efficacy, depending on [...]

There was further good news on the vaccine front, with Moderna reporting almost 95% efficacy for its vaccine. However, stock market gains were limited by signs that the [...]

Global stock markets soared on indications that the BioNTech/Pfizer vaccine was 90% effective in protecting against Covid-19. Travel and hospitality stocks were among the [...]

Financial markets were volatile as the outcome of the US election was far from clear. However, risk assets later surged as investors started to consider the positive aspects [...]